Filing Details
- Accession Number:
- 0001209191-20-055519
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-10-21 19:09:41
- Reporting Period:
- 2020-10-19
- Accepted Time:
- 2020-10-21 19:09:41
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1679363 | Morphic Holding Inc. | MORF | Pharmaceutical Preparations (2834) | 473878772 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1779976 | Alexey Lugovskoy | C/O Morphic Holding, Inc. 35 Gatehouse Drive, A2 Waltham MA 02451 | Chief Development Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2020-10-19 | 100 | $28.22 | 95,148 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.